Skip to main content
Caplight Logo









MiraBiologics Inc.

MiraBiologics Inc.

Private
TokyoHealthcare & Life Scienceshttps://mirabiologics.com/

Last Round

VC Round

Jan 1, 2020

Company Overview

MiraBiologics Inc. is a biotechnology company that develops multifunctional biopharmaceuticals and protein-based therapeutics using its proprietary LassoGraft Technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryprotein engineeringbiopharmaceuticalsbispecific antibodiesmultispecific antibodiescyclic peptidesbiologicstherapeutic agentsdrug developmentbiotech partnerpharma collaborationtarget-binding proteinsdrug discovery platformbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiraBiologics Inc. Comparables

Compare MiraBiologics Inc. with similar companies based on industry and business-model similarity.

MiraBiologics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Veneno Technologies Co., Ltd.
80%
MOLCURE Inc.
79%
Y-Biologics
77%

MiraBiologics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 1, 2020

Key People

Founding team and executive leadership

Jun Igarashi

CEO

Executive Team

MiraBiologics Inc. Investors

Notable investors and investment history

MiraBiologics Inc. investors
InvestorRounds
Shinsei Capital PartnersVC Round
SMBC Venture CapitalVC Round
SBI Investment Co., Ltd.VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 11, 2024

    Grew 100% QoQ, from 4 to 8 employees.

  • Sep 10, 2024

    Grew 167% QoQ, from 3 to 8 employees.

MiraBiologics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MiraBiologics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiraBiologics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range5
Year Founded2017
Last FundingJan 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?